Before you go!

Sign up for the FREE weekly email newsletter from the publishers of American Nurse Today. You’ll get breaking news features, exclusive investigative stories, and more — delivered to your inbox.

Sign up today!

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

FDA announces new recommendations for simvastatin dosage

The U.S. Food and Drug Administration (FDA) is recommending that 80 mg simvastatin (Zocor) not be prescribed to new patients because of the associated risk of myopathy, particularly within the first 12 months of use. The FDA recommends that the 80 mg dose be used only in patients who have been taking that amount for at least 12 months and have not experienced any muscle toxicity. Read more.

Leave a Reply

You have to agree to the comment policy.


Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing